OBETAT is dedicated for development and commercialization of breakthrough therapy in meeting unmet needs of treating Severe Obesity and Prader Willi Syndrome (orphan disease) in USA and global market.

Obetat has three peptides compounds (with amnio acids 26, 38 71) for Severe Obesity, Prade Willin Syndrome, Diabetes, and Fatty Liver Disease.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s